250 related articles for article (PubMed ID: 19021146)
21. Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia.
Sen U; Sathnur PB; Kundu S; Givvimani S; Coley DM; Mishra PK; Qipshidze N; Tyagi N; Metreveli N; Tyagi SC
Am J Physiol Cell Physiol; 2012 Jul; 303(1):C41-51. PubMed ID: 22517358
[TBL] [Abstract][Full Text] [Related]
22. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.
Eberhardt RT; Forgione MA; Cap A; Leopold JA; Rudd MA; Trolliet M; Heydrick S; Stark R; Klings ES; Moldovan NI; Yaghoubi M; Goldschmidt-Clermont PJ; Farber HW; Cohen R; Loscalzo J
J Clin Invest; 2000 Aug; 106(4):483-91. PubMed ID: 10953023
[TBL] [Abstract][Full Text] [Related]
23. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis.
Sen U; Munjal C; Qipshidze N; Abe O; Gargoum R; Tyagi SC
Am J Nephrol; 2010; 31(5):442-55. PubMed ID: 20395677
[TBL] [Abstract][Full Text] [Related]
24. Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid.
Tyagi N; Kandel M; Munjal C; Qipshidze N; Vacek JC; Pushpakumar SB; Metreveli N; Tyagi SC
J Orthop Res; 2011 Oct; 29(10):1511-6. PubMed ID: 21469179
[TBL] [Abstract][Full Text] [Related]
25. PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice.
Rodriguez WE; Sen U; Tyagi N; Kumar M; Carneal G; Aggrawal D; Newsome J; Tyagi SC
Int J Biol Sci; 2008 Aug; 4(4):236-44. PubMed ID: 18690293
[TBL] [Abstract][Full Text] [Related]
26. Moderate hyperhomocysteinemia decreases endothelial-dependent vasorelaxation in pregnant but not nonpregnant mice.
Powers RW; Gandley RE; Lykins DL; Roberts JM
Hypertension; 2004 Sep; 44(3):327-33. PubMed ID: 15249551
[TBL] [Abstract][Full Text] [Related]
27. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.
Tyagi N; Gillespie W; Vacek JC; Sen U; Tyagi SC; Lominadze D
J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943
[TBL] [Abstract][Full Text] [Related]
28. Effect of long-term chronic hyperhomocysteinemia on retinal structure and function in the cystathionine-β-synthase mutant mouse.
Xiao H; Wang J; Barwick SR; Yoon Y; Smith SB
Exp Eye Res; 2022 Jan; 214():108894. PubMed ID: 34906600
[TBL] [Abstract][Full Text] [Related]
29. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration.
Aram G; Potter JJ; Liu X; Torbenson MS; Mezey E
Hepatology; 2008 Jun; 47(6):2051-8. PubMed ID: 18506890
[TBL] [Abstract][Full Text] [Related]
30. Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Mishra PK; Tyagi N; Sen U; Joshua IG; Tyagi SC
Cardiovasc Diabetol; 2010 Sep; 9():49. PubMed ID: 20828387
[TBL] [Abstract][Full Text] [Related]
31. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.
Lentz SR; Erger RA; Dayal S; Maeda N; Malinow MR; Heistad DD; Faraci FM
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H970-5. PubMed ID: 10993757
[TBL] [Abstract][Full Text] [Related]
32. Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia.
Muradashvili N; Tyagi R; Metreveli N; Tyagi SC; Lominadze D
J Cereb Blood Flow Metab; 2014 Sep; 34(9):1472-82. PubMed ID: 24865997
[TBL] [Abstract][Full Text] [Related]
33. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.
Sun Y; Carretero OA; Xu J; Rhaleb NE; Wang F; Lin C; Yang JJ; Pagano PJ; Yang XP
Hypertension; 2005 Dec; 46(6):1355-61. PubMed ID: 16286571
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.
Steed MM; Tyagi SC
Antioxid Redox Signal; 2011 Oct; 15(7):1927-43. PubMed ID: 21126196
[TBL] [Abstract][Full Text] [Related]
35. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.
Namekata K; Enokido Y; Ishii I; Nagai Y; Harada T; Kimura H
J Biol Chem; 2004 Dec; 279(51):52961-9. PubMed ID: 15466479
[TBL] [Abstract][Full Text] [Related]
36. Activation of inducible nitric oxide synthase increases MMP-2 and MMP-9 levels in ApoE-knockout mice.
Chen Y; Aratani Y; Osawa T; Fukuyama N; Tsuji C; Nakazawa H
Tokai J Exp Clin Med; 2008 Apr; 33(1):28-34. PubMed ID: 21318961
[TBL] [Abstract][Full Text] [Related]
37. GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice.
Kumar M; Tyagi N; Moshal KS; Sen U; Pushpakumar SB; Vacek T; Lominadze D; Tyagi SC
Brain Res; 2008 Jul; 1221():147-53. PubMed ID: 18547546
[TBL] [Abstract][Full Text] [Related]
38. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
Dayal S; Bottiglieri T; Arning E; Maeda N; Malinow MR; Sigmund CD; Heistad DD; Faraci FM; Lentz SR
Circ Res; 2001 Jun; 88(11):1203-9. PubMed ID: 11397788
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.
Jo H; Otani H; Jo F; Shimazu T; Okazaki T; Yoshioka K; Fujita M; Kosaki A; Iwasaka T
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):485-93. PubMed ID: 21554376
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction.
Weiss N; Zhang YY; Heydrick S; Bierl C; Loscalzo J
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12503-8. PubMed ID: 11606774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
